Saint Petersburg, April 22, 2020: On April 20, the Russian Ministry of Health approved the first Russian original PD-1 inhibitor Forteca®…
New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…
New Delhi, May 18, 2018: Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis The…
New Delhi, April 28, 2018: In March 2018, BIOCAD analyzed results from its Phase II study in which the original…
The police opened a criminal case over fraud on an especially large scale against former employees of the Russian subsidiary…
New Delhi, February 21, 2018: In January 2018, BIOCAD’s infliximab biosimilar was approved in Russia. The approval was based on…